Showing results (91-100 of 179) with videos related to

Sort By:
Pageof 18
Geburtshilfe Und Frauenheilkunde|February 1, 1990
[Modulation of hCG synthesis by alpha tumor necrosis factor in JAR choriocarcinoma cells]C Marth, S Madersbacher, M Herold, et al.
American Journal of Obstetrics and Gynecology|April 16, 1999
Ovarian preservation in the surgical treatment of cervical carcinomaG H Windbichler, E Müller-Holzner, G Nicolussi-Leck, et al.
Breast Cancer Research and Treatment|January 1, 1993
Progesterone receptors in routinely paraffin-embedded primary breast carcinomas and lymph node metastasesE Müller-Holzner, A G Zeimet, G Daxenbichler, et al.
Anticancer Research|April 19, 2000
Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patientsB Abendstein, G Daxenbichler, G Windbichler, et al.
Geburtshilfe Und Frauenheilkunde|April 1, 1992
[The value of nuclear magnetic resonance tomography in diagnosing invasive trophoblast disease]G Helweg, M Pessar, K Wicke, et al.
European Journal of Gynaecological Oncology|July 3, 2008
Cervical cancer associated with genital prolapse--a brief review of the literature and long-term results of successful treatment with radiochemotherapy and surgery in a very frail patientD Reimer, A Sztankay, I Steppan, et al.
Molecular Biotherapy|January 1, 1989
Modulation of secretion of human chorionic gonadotropin by biologic response modifiers on term placenta and choriocarcinoma cellsC Marth, M Brattia, E Müller-Holzner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 4, 2006
Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II studyC Marth, G H Windbichler, H Hausmaninger, et al.
Journal of Interferon Research|April 1, 1987
Characterization of an interferon-resistant mutant of the human breast cancer cell line BT-20C Marth, G Gastl, J Zech, et al.
Cancer Research|July 1, 1985
Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expressionG Gastl, C Marth, E Leiter, et al.
Pageof 18